"丙肝"标签列表

[APASL2013]Could Vitamin D Supplementation Improve Response to Antiviral Treatment for Hepatitis C Virus Genotype 4?2013-06-07

[APASL2013]Responses and Adverse Effects of Triple Therapy with Telaprevir， PegIFN and Ribavirin in Patients with Hepatitis C Virus Infection2013-06-07

[APASL2013]无干扰素，无利巴韦林治疗方案Daclatasvir，Asunaprevir和BMS-791325治疗慢性HCV基因型1型感染初治患者2013-06-07

[APASL2013]N-CORE：聚乙二醇干扰素Alfa-2a/利巴韦林（PegIFN-alfa/RBV）治疗无快速病毒学应答的HCV G2或3型患者的持续病毒学应答率2013-06-07

[APASL2013]补充维生素D可以提高丙型肝炎病毒基因型4型抗病毒治疗应答吗？2013-06-07

[APASL2013]抗病毒治疗作为HCV相关肝硬化肝细胞癌（HCC）复发的二级预防：一项病例对照研究2013-06-07

[APASL2013]特拉匹韦，PegIFN和利巴韦林三联疗法治疗丙型肝炎病毒感染患者的病毒学应答和不良反应2013-06-07

[APASL2013]由利托那韦增强的danoprevir（DNVr）联合PegIFNα-2a干扰素（40KD）/利巴韦林（P/R）治疗HCV基因型（G）1b感染先前部分/无应答者的SVR率高达91％2013-06-07

[APASL2013]Alisporivir（ALV）+利巴韦林（RBV）（+/-干扰素）治疗HCV G2/3初治患者24周可获得高HCV持续清除率：最终SVR242013-06-07

[APASL2013]A Novel Method for Non-Invasive Diagnosis of Hepatitis C Virus Using Electromagnetic Signal Detection: A Multicenter International Study2013-06-07

[APASL2013]一种新型使用电磁信号检测丙型肝炎病毒的非侵入性诊断方法：国际多中心研究2013-06-07

[APASL2013]48 Weeks of Therapy Might Not Be Needed for the Patients with HCV Genotype 2 without RVR like EASL Guideline2013-06-07

[APASL2013]无RVR的HCV基因型2型患者也许并不像EASL指南所建议的那样需要48周治疗2013-06-07

[APASL2013]All Oral Therapy with Sofosbuvir+Ribavirin for 12 or 16 Weeks in Treatment Experienced Genotype 2/3 HCV-Infected Patients: The FUSION Trial2013-06-07

[APASL2013]An Interferon-free， Ribavirin-free Regimen of Daclatasvir， Asunaprevir， and BMS-791325 in Treatment-Naive Patients with Genotype 1 Chronic Hepatitis C Virus Infection2013-06-07

[APASL2013]Antiviral therapy as secondary prophylaxis of hepatocellular carcinoma (HCC) recurrence in HCV-related cirrhosis: a case-control study2013-06-07

[APASL2013]Up to 91% SVR rates with ritonavir-boosted danoprevir (DNVr) plus PegIFN alfa-2a (40KD)/ribavirin(P/R) in HCV genotype (G)1b-infected prior partial/null-responders2013-06-07

[APASL2013]High-Rates of Sustained-HCV-Clearance Following 24-Weeks of Alisporivir (ALV) + Ribavirin (RBV) (+/-IFN-add-on) in HCV G2/3 Treatment-Naive Patients: Final SVR242013-06-07

[APASL2013]Interferon-free Regimens of ABT-450/r， ABT-267， ABT-333 +/- Ribavirin Achieve High SVR12 Rates in Patients with Chronic HCV Genotype 1b2013-06-07

丙型肝炎治疗的前期探索2013-06-06